Sector revisions DexCom, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-11 EDT			5-day change	1st Jan Change
83.03 ^USD	-1.75%		-5.54%	+25.10%

09-10	DexCom, Inc. Announces Appointment of Glenn S. Boehnlein as Director, Member of Operations & Innovation Committee and Audit Committee, Effective September 10, 2026	CI
09-09	DexCom, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:00 AM

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	DEXCOM, INC.							25
	ABBOTT LABORATORIES							25
	MEDTRONIC PLC							25
	CENCORA, INC.							13
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							12
	MEDLINE INC.							25
	WEST PHARMACEUTICAL SERVICES, INC.							16
	TERUMO CORPORATION							13
	SARTORIUS STEDIM BIOTECH							14
	STERIS PLC							8
	ZIMMER BIOMET HOLDINGS, INC.							21
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	BAXTER INTERNATIONAL INC.							11
	ALIGN TECHNOLOGY, INC.							15
	AVANTOR, INC.							15
	GLOBUS MEDICAL, INC.							13
	BIO-RAD LABORATORIES, INC.							5
	DEMANT A/S							20
	Average							16
	Weighted average by Cap.							19